Lisata Therapeutics, Inc. (NASDAQ: LSTA) related to its sale to Smithfield Foods, Inc. Under the terms of the proposed transaction, Lisata shareholders are expected to receive $4.00per share in cash, and one non-transferable contingent value right entitling Lisata shareholders to receive potential payments under certain conditions.